John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 54,897 shares at $67.02 ($3.7M) on 2016-04-19, disclosed to the SEC on 2016-04-21.
Open-market sale of $3.7M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.02 | 9,371 | $628K | 17.0% |
| 2 | $67.02 | 9,371 | $628K | 17.0% |
| 3 | $68.00 | 5,405 | $368K | 9.9% |
| 4 | $68.71 | 300 | $21K | 0.6% |
| 5 | $68.71 | 300 | $21K | 0.6% |
| 6 | $67.38 | 12,670 |
| $854K |
| 23.1% |
| 7 | $67.38 | 12,670 | $854K | 23.1% |
| 8 | $68.24 | 2,405 | $164K | 4.4% |
| 9 | $68.24 | 2,405 | $164K | 4.4% |
| Total | $67.41 avg | 54,897 | $3.7M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |